Sitravatinib

• Description :

  A novel, broad spectrum small molecule inhibitor that blocks a wide array of RTKs known to be amplified/overexpressed in sarcomas, including c-Kit, PDGFRβ, PDGFRα, c-Met, and Axl (IC50=1.5-30 nM) .

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  629.6763

• Molecular Formula :

  C33H29F2N5O4S

• Notes :

  Research use only, not for human use.

• Receptor :

  DDR2|EPHA3|Axl|Mer|VEGFR3 (FLT4)

• CAS Number :

  1123837-84-2